No abstract available
Keywords:
breast cancer; druggable mutations; drugs; genome analysis; personalized treatment; precise prediction; therapeutic response.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / prevention & control*
-
Female
-
Genetic Predisposition to Disease
-
Genome, Human
-
Humans
-
Precision Medicine
-
Quinolines / therapeutic use
-
Receptor, ErbB-2 / metabolism
-
Translational Research, Biomedical
Substances
-
Antineoplastic Agents
-
Quinolines
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
neratinib